Atezolizumab With Neoadjuvant Chemotherapy for Patients With Newly-Diagnosed Advanced-Stage Ovarian Cancer
Clinical trial NCT03394885 · COMPLETED
Trial details
- NCT number
- NCT03394885
- Sponsor
- Duke University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-19
- Primary completion
- 2020-07-20
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.